FR2777193B1 - PARTICLE WITH A CHELATING HYDROXAMIC GROUP OF METAL IONS AND THEIR USE IN COSMETICS OR PHARMACY - Google Patents

PARTICLE WITH A CHELATING HYDROXAMIC GROUP OF METAL IONS AND THEIR USE IN COSMETICS OR PHARMACY

Info

Publication number
FR2777193B1
FR2777193B1 FR9804611A FR9804611A FR2777193B1 FR 2777193 B1 FR2777193 B1 FR 2777193B1 FR 9804611 A FR9804611 A FR 9804611A FR 9804611 A FR9804611 A FR 9804611A FR 2777193 B1 FR2777193 B1 FR 2777193B1
Authority
FR
France
Prior art keywords
metal ions
pharmacy
cosmetics
chelating
particle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9804611A
Other languages
French (fr)
Other versions
FR2777193A1 (en
Inventor
Marie Christine Levy
Chantal Buffevant
Isabelle Bonnet
Eric Perrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
Coletica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coletica SA filed Critical Coletica SA
Priority to FR9804611A priority Critical patent/FR2777193B1/en
Priority to US09/108,670 priority patent/US6132750A/en
Priority to ES9900769A priority patent/ES2156074B1/en
Priority to KR1019990012998A priority patent/KR100559210B1/en
Priority to JP10618399A priority patent/JP3503741B2/en
Priority to DE1999116896 priority patent/DE19916896B4/en
Publication of FR2777193A1 publication Critical patent/FR2777193A1/en
Application granted granted Critical
Publication of FR2777193B1 publication Critical patent/FR2777193B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/594—Mixtures of polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/654—The particulate/core comprising macromolecular material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
    • Y02W10/00—Technologies for wastewater treatment
    • Y02W10/30—Wastewater or sewage treatment systems using renewable energies
    • Y02W10/37—Wastewater or sewage treatment systems using renewable energies using solar energy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2989—Microcapsule with solid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Rheumatology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)

Abstract

The invention relates to small sized particles. These particles comprise at least on the surface thereof a wall composed of a mixture of at least one protein and at least one polysaccharide which are cross-linked, preferably by interfacial cross-linking with a polyfunctional acylating agent which forms at least amide and ester bonds, and optionally anhydride bonds with amine, hydroxyl or carboxyl functions of the protein and of the polysaccharide, and which comprise hydroxamic groups on the surface thereof for chelating metal ions. These particles can be used in cosmetics or in pharmacy notably for the chelation or release of metal ions.
FR9804611A 1998-04-14 1998-04-14 PARTICLE WITH A CHELATING HYDROXAMIC GROUP OF METAL IONS AND THEIR USE IN COSMETICS OR PHARMACY Expired - Lifetime FR2777193B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9804611A FR2777193B1 (en) 1998-04-14 1998-04-14 PARTICLE WITH A CHELATING HYDROXAMIC GROUP OF METAL IONS AND THEIR USE IN COSMETICS OR PHARMACY
US09/108,670 US6132750A (en) 1998-04-14 1998-07-01 Particles of cross-linked proteins and polysaccharides with hydroxamic groups for chelating metals and their uses notably in cosmetics
ES9900769A ES2156074B1 (en) 1998-04-14 1999-04-13 NEW PARTICLES WITH A BELLING METAL ION SURFACE, PROCEDURE FOR PREPARATION AND APPLICATIONS.
KR1019990012998A KR100559210B1 (en) 1998-04-14 1999-04-13 Small particles having a mixed wall of cross-linked protein and cross-linked polysaccharide and containing hydrosulfide on its surface, chelating metal ions, manufacturing method and various uses thereof
JP10618399A JP3503741B2 (en) 1998-04-14 1999-04-14 Small particles having a hydroxam group that chelates metal ions on the surface and having a mixed wall of cross-linked protein and cross-linked polysaccharide, a method for producing the same, and various uses thereof particularly in cosmetics, pharmaceuticals, and agricultural foods
DE1999116896 DE19916896B4 (en) 1998-04-14 1999-04-14 Small dimension particles comprising a wall of a mixture of cross-linked proteins and polysaccharides containing surface metal ion chelating hydroxam groups, processes for their preparation and their various uses, especially in the cosmetic, pharmaceutical and food industries

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9804611A FR2777193B1 (en) 1998-04-14 1998-04-14 PARTICLE WITH A CHELATING HYDROXAMIC GROUP OF METAL IONS AND THEIR USE IN COSMETICS OR PHARMACY

Publications (2)

Publication Number Publication Date
FR2777193A1 FR2777193A1 (en) 1999-10-15
FR2777193B1 true FR2777193B1 (en) 2001-06-08

Family

ID=9525200

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9804611A Expired - Lifetime FR2777193B1 (en) 1998-04-14 1998-04-14 PARTICLE WITH A CHELATING HYDROXAMIC GROUP OF METAL IONS AND THEIR USE IN COSMETICS OR PHARMACY

Country Status (6)

Country Link
US (1) US6132750A (en)
JP (1) JP3503741B2 (en)
KR (1) KR100559210B1 (en)
DE (1) DE19916896B4 (en)
ES (1) ES2156074B1 (en)
FR (1) FR2777193B1 (en)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317882B1 (en) * 2000-07-31 2003-07-15 S I C It S P A FUNGICID AND BACTERICIDAL ACTIVES BASED ON COPPER AND THEIR USE.
GB0025414D0 (en) 2000-10-16 2000-11-29 Consejo Superior Investigacion Nanoparticles
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US20030096013A1 (en) * 2000-12-22 2003-05-22 Jane Werling Preparation of submicron sized particles with polymorph control
US7037528B2 (en) 2000-12-22 2006-05-02 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US7193084B2 (en) * 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
DE10103349B4 (en) * 2001-01-25 2006-11-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Use of metal chelate complexes as UV protectants for polymeric materials, inorganic-organic hybrid polymers and methods of protecting UV-sensitive materials
US20050230255A1 (en) * 2001-03-30 2005-10-20 Sumner Lloyd W Silver destaining method
US20040126900A1 (en) * 2001-04-13 2004-07-01 Barry Stephen E High affinity peptide- containing nanoparticles
KR100483193B1 (en) * 2001-06-05 2005-04-14 꼴레띠까 Treated water-insoluble solid particles, preparation and use
FR2825293B1 (en) * 2001-06-05 2004-05-07 Coletica SOLID WATER INSOLUBLE PARTICLES TREATED, PREPARATION AND USE
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
CN1558755A (en) 2001-09-26 2004-12-29 ���ع��ʹ�˾ Preparation of submicron-sized nanoparticles by dispersion and removal of solvent or liquid phase
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
KR20010106359A (en) * 2001-10-30 2001-11-29 조석형 Chelate compound for animals feed
GB2381749A (en) * 2001-11-08 2003-05-14 Alan John Taylor Powders having contact biocidal properties comprising a polymer and silver
US20030180338A1 (en) * 2002-01-08 2003-09-25 Pascal Arnaud Care or makeup composition, comprising a non-volatile hydrocarbon oil, a particulate phase and a specific dispersant
FR2834453B1 (en) * 2002-01-08 2006-01-06 Oreal COMPOSITION FOR MAKE-UP OR CARE OF KERATIN MATERIALS COMPRISING A NON-VOLATILE HYDROCARBON OIL, A PARTICULAR PHASE AND A PARTICULAR DISPERSING AGENT
DE10239029A1 (en) * 2002-08-21 2004-03-04 Coty B.V. Cosmetic and dermatological preparation with proteins for skin lightening
US7485259B2 (en) * 2002-10-08 2009-02-03 Eldred Bradley J Organic compound and metal ion synergistic disinfection and purification system and method of manufacture
CA2503492A1 (en) * 2002-10-25 2004-05-06 Essentia Biosystems, Inc. Implantable medical devices using zinc
CN103181566A (en) * 2003-04-03 2013-07-03 帝斯曼知识产权资产管理有限公司 Powderous formulations of fat-soluble active ingredients
ES2226567B1 (en) * 2003-06-20 2006-07-01 Universidad De Santiago De Compostela NANOPARTICULAS OF HIALURONIC ACID.
ES2232287B1 (en) * 2003-07-04 2006-11-01 Advanced In Vitro Cell Technologies, S.L. POLYOXYETHYLATE DERIVATIVES NANOPARTICLES.
US7361275B2 (en) * 2004-04-13 2008-04-22 Eastman Kodak Company Use of derivatized nanoparticles to minimize growth of micro-organisms in hot filled drinks
US20050226911A1 (en) * 2004-04-13 2005-10-13 Bringley Joseph F Article for inhibiting microbial growth in physiological fluids
US7258786B2 (en) * 2004-04-13 2007-08-21 Eastman Kodak Company Container for inhibiting microbial growth in liquid nutrients
US7384545B2 (en) * 2004-04-13 2008-06-10 Eastman Kodak Company Container for inhibiting microbial growth in liquid nutrients
US7381334B2 (en) * 2004-04-13 2008-06-03 Eastman Kodak Company Method for inhibiting microbial growth in liquid nutrients
US20050224419A1 (en) * 2004-04-13 2005-10-13 Eastman Kodak Company Use of derivatized nanoparticles to minimize growth of micro-organisms in hot filled drinks
US7357863B2 (en) * 2004-04-13 2008-04-15 Eastman Kodak Company Container for inhibiting microbial growth in liquid nutrients
ES2246695B1 (en) * 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. STIMULATING COMPOSITION OF THE IMMUNE RESPONSE THAT INCLUDES NANOPARTICLES BASED ON A COPYLIMER OF METHYL VINYL ETER AND MALEIC ANHYDRIDE.
ES2246694B1 (en) * 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. PEGILATED NANOPARTICLES.
US20050276862A1 (en) * 2004-06-15 2005-12-15 Bringley Joseph F Iron sequestering antimicrobial composition
KR100814012B1 (en) 2004-06-24 2008-03-14 정한춘 Method for producing chitosan-selenium complex
MX2007013725A (en) 2005-05-05 2008-04-09 Sensient Flavors Inc Production of beta-glucans and mannans.
EP1792544A1 (en) * 2005-11-30 2007-06-06 Unilever N.V. Zinc fortified food product and additive
JP5249500B2 (en) * 2005-12-16 2013-07-31 国立大学法人茨城大学 Metal ion detection method
JP5147699B2 (en) * 2005-12-20 2013-02-20 富士フイルム株式会社 Protein nanoparticles and uses thereof
WO2007135164A1 (en) * 2006-05-24 2007-11-29 Advanced In Vitro Cell Technologies, S.A. Nanoparticles of chitosan and hyaluronan for the administration of active molecules
US20080112988A1 (en) * 2006-11-14 2008-05-15 Ancient Stones, Inc. Composition and method for cosmetic vitalization and stabilization
CN100431691C (en) * 2006-12-29 2008-11-12 南开大学 Preparation and application of a novel chitosan derivative
JP5439691B2 (en) * 2007-03-06 2014-03-12 日立化成株式会社 High valent metal ion scavenger
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US20090187060A1 (en) * 2008-01-22 2009-07-23 E-Z-Em, Inc. Method and Formulation for Neutralizing Toxic Chemicals and Materials
US7932326B2 (en) * 2008-04-16 2011-04-26 The University Of Kentucky Research Foundation Chelating compounds and immobilized tethered chelators
US9259670B2 (en) 2008-04-16 2016-02-16 The University Of Kentucky Research Foundation Flow-through filter to remove aluminum from medical solutions
US9139456B2 (en) 2008-04-16 2015-09-22 The Curators Of The University Of Missouri Chelating compounds and immobilized tethered chelators
KR101089063B1 (en) 2009-11-19 2011-12-05 강원대학교산학협력단 Method for preparing pectin nanoparticle cosmetic composition of starfish-derived low molecular collagen peptide and composition thereof
WO2012022034A1 (en) 2010-08-18 2012-02-23 Unilever Plc Improvements relating to fabric treatment compositions comprising targeted benefit agents
CN102228178B (en) * 2011-06-18 2013-04-17 赤峰多维尔生物工程有限公司 Granular substance containing calcium, iron, zinc and selenium
US9351910B2 (en) 2011-08-24 2016-05-31 Conopco, Inc. Benefit agent delivery particles comprising dextran
JP2013048564A (en) * 2011-08-30 2013-03-14 Leda Co Ltd Method for extracting placenta extract and nutrient supplement
DE102011088931A1 (en) * 2011-12-19 2013-06-20 Beiersdorf Ag Use of hydroxamic acids for stabilizing cosmetic and / or dermatological preparations
FR2997406B1 (en) * 2012-10-25 2015-07-03 Basf Beauty Care Solutions F HYALURONATE AND GLUCOMANNAN POLYMER
CN102964459A (en) * 2012-11-02 2013-03-13 华南理工大学 Lentinan calcium complex, and preparation method and application thereof
JP5610410B2 (en) * 2013-01-28 2014-10-22 国立大学法人茨城大学 Agent for collecting and detecting high-valent metal ions
FR3032721B1 (en) * 2015-02-12 2020-03-27 Bionov MIX OF PURIFIED SOD OF PLANT ORIGIN
PL3278102T3 (en) * 2015-04-24 2022-08-22 Colgate-Palmolive Company Porous protein particles as carriers for actives
JP7009371B2 (en) 2015-12-29 2022-01-25 ガルデルマ エス．エー． Methods for deacetylating biopolymers
PT3623390T (en) * 2016-05-31 2023-10-27 Galderma Sa Carbohydrate crosslinker
CN106519071A (en) * 2016-10-25 2017-03-22 湖北医药学院 Synthetic method of antitumor drug 6-hydroxy seleninic acid esterification chitosan copper
WO2018165267A1 (en) * 2017-03-07 2018-09-13 Hppe, Llc Polysaccharide compositions and particulate materials coated therewith
EP3395422B1 (en) * 2017-04-24 2022-01-26 Biotage AB Removal of metal ions from essential oils
CN109293802B (en) * 2018-09-13 2020-11-03 福建农林大学 Agar oligosacchride iron and preparation method thereof
JP7067450B2 (en) * 2018-12-14 2022-05-16 Ｊｆｅエンジニアリング株式会社 Method for producing hydroxamic acid resin and method for purifying zirconium
CA3160575A1 (en) 2019-12-02 2021-06-10 Johan Olsson High molecular weight esthetic compositions
MX2023003016A (en) 2020-09-22 2023-04-10 Swimc Llc Chitosan-containing coating compositions.
CN113351256B (en) * 2021-06-11 2023-09-26 广西民族大学 Cuttlefish melanin-based nano silver composite material, preparation method and catalytic application thereof
CN115212285B (en) * 2022-06-10 2025-07-08 汕头大学 Fish gelatin polypeptide nano material prepared based on self-condensation reaction and application thereof
CN115887263A (en) * 2022-12-09 2023-04-04 中国辐射防护研究院 Decontamination agent for nuclide pollution of wound and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395620A (en) * 1989-01-31 1995-03-07 Coletica Biodegradable microcapsules having walls composed of crosslinked atelocollagen and polyholoside
FR2642329B1 (en) * 1989-01-31 1991-05-24 Bioetica Sa USE OF ATELOCOLLAGEN AND GLYCOSAMINOGLYCAN SOLUTIONS FOR THE MANUFACTURE OF MICROCAPSULES, MICROCAPSULES MADE THEREOF, METHODS OF MANUFACTURING SUCH MICROCAPSULES AND COSMETIC OR PHARMACEUTICAL OR FOOD COMPOSITIONS CONTAINING THE SAME
FR2680005B1 (en) * 1991-08-01 1994-09-02 Coletica USE OF COLLAGEN AS A SOLID SUPPORT FOR FIXING A SENSOR CAPABLE OF REACTING SPECIFICALLY WITH AN ELEMENT TO BE DETECTED IN A BIOLOGICAL, REACTIVE AND IMPLEMENTING METHOD.
FR2683159B1 (en) * 1991-10-31 1994-02-25 Coletica PROCESS FOR PRODUCING WALL NANOCAPSULES BASED ON CROSSLINKED PROTEINS; NANOCAPSULES THUS OBTAINED AND COSMETIC, PHARMACEUTICAL AND FOOD COMPOSITIONS INCLUDING APPLICATION.
FR2688422A1 (en) * 1992-03-11 1993-09-17 Coletica MICROCAPSULES WITH POLYSACCHARIDE WALLS CONTAINING PRIMARY ALCOHOL FUNCTIONS, AND COMPOSITIONS CONTAINING SAME.

Also Published As

Publication number Publication date
US6132750A (en) 2000-10-17
ES2156074B1 (en) 2002-02-01
FR2777193A1 (en) 1999-10-15
DE19916896A1 (en) 1999-10-21
ES2156074A1 (en) 2001-06-01
KR100559210B1 (en) 2006-03-15
KR19990083166A (en) 1999-11-25
JP2000073043A (en) 2000-03-07
DE19916896B4 (en) 2006-03-02
JP3503741B2 (en) 2004-03-08

Similar Documents

Publication Publication Date Title
FR2777193B1 (en) PARTICLE WITH A CHELATING HYDROXAMIC GROUP OF METAL IONS AND THEIR USE IN COSMETICS OR PHARMACY
TNSN98187A1 (en) α ARYL - N - ALKYNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2774702B1 (en) ASSOCIATION BASED ON MICROFIBRILLES AND MINERAL PARTICLES PREPARATION AND USES
AU3978497A (en) Improvements in polymer compositions for chemotherapy and methods of treatment using the same
CY2013008I1 (en) APPETITE SUPPRESSANT PEPTIDE, COMPOSITIONS AND USE THEREOF
TR200000374T2 (en) Treatment of acute lung injury and fibrosis with alfavbeta6 antagonists.
EA200100024A1 (en) COMPOSITION TABLETS WITH DELAVIRDIN
BR9709588A (en) Apparatus and method for separating particles with a rotating magnetic system
TR199901571T2 (en) T�berk�lozun imm�noterapi te�hisi i�in bile�ikler ve y�ntemler.
MX9701308A (en) Paints made based on water for signs in road.
GB9825714D0 (en) Improved pipeline pig and applications for use thereof
AU2002221702A1 (en) Pharmaceutical compositions
NO990935D0 (en) Crosslinked copolymers based on polymers containing carboxylic acid
DK1328612T3 (en) Particle with substituted polyvinyl alcohol coating
BR9910860A (en) Use of cyclosporins in the treatment of inflammatory autoimmune diseases
GB9920124D0 (en) Novel photoresist monomer having hydroxy group and carboxy group copolymer thereof and photoresist composition using the same
FR2787798B1 (en) NOVEL POLYSILOXANE PARTICLES AND THEIR APPLICATION AS COSMETIC AGENTS
EP1089732A4 (en) COMPOSITIONS AND METHODS FOR TREATING HIGH CHOLESTEROLEMIA
GR3035839T3 (en) Assay method
TR200102041T2 (en) 2-arylmino heterocycles substituted as progesterone receptor binding agents
EP0639600A3 (en) Composition of biodegradable resin and anti-soil paint.
BR9713043A (en) Composition for cleaning rigid surfaces.
ATE208692T1 (en) DEVICE FOR FRACTIONING AND SCATTERING PARTICULARLY FIBROUS PARTICLES
ATE254109T1 (en) NEW POLYMERIZABLE ACYLIMIDAZOLIDINONE MONOMERS
ATE284754T1 (en) BIOSORBENTS FOR METAL IONS AND METHOD FOR THE PRODUCTION THEREOF

Legal Events

Date Code Title Description
CD Change of name or company name
PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20